Fist Assist Devices, LLC Announces Release of the p-FACT Cohort Data
FA-1 Device Significantly Dilates the Perforator Vein for Improved EndoAVF Placement.
August 19, 2021
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
View the latest clinical trials, studies, data, and updates.
5-Yr Results Of The GORE® EXCLUDER® Iliac Branch Endoprosthesis Pivotal U.S. Multicenter Study Confirm Safety, Efficacy and Durability
“The positive outcomes from this five-year study validate the effectiveness and durability of the GORE EXCLUDER Iliac Branch Endoprosthesis for the treatment of iliac artery aneurysms,” said Darren B. Schneider, M.D., the study National Principal Investigator and Chief of Vascular Surgery and Endovascular Therapy at Penn Medicine and the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. “
August 19, 2021
Inspira Technologies Completes Pump Bench Study: Reaches Important Milestone
Dagi Ben-Noon, Inspira’s Chief Executive Officer, stated: “The pump is one of the core components of our ART device. The pump experiment represents an important milestone for us as it enables us to progress to manufacturing phase.”
August 18, 2021
First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon
The aim of the study is to assess the feasibility and safety of angioplasty with a sirolimus-eluting balloon in patients with ED and distal internal pudendal and/or penile artery stenotic disease, using Plain Old Balloon (POB) angioplasty as a comparator.
August 17, 2021
New Study Shows Advanced Treatment (AT) for Management of LEDUs Among Medicare Beneficiaries is Associated with Significant Reductions in Major & Minor Amputation, Emergency Department Use, & Hospital Readmissions vs. LEDUs Managed Without AT (NAT)
“The data derived from this study are important for a number of reasons,” noted Dr. David G. Armstrong, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine of the University of Southern California. Read more.
August 17, 2021
SELUTION SLR Sirolimus Drug Eluting Balloon Clinical Trial Completed
The 12-month data from PRESTIGE was presented at LINC 2021 in January, showing sustained benefits up to one year. 18-month data is to be presented at VIVA in October this year, where it is anticipated that these benefits will be further sustained.
August 12, 2021
